Direct mechanical ventricular actuation cardiac arrest humans clinical feasibility trial Direct mechanical ventricular actuation DMVA non-blood-contacting method biventricular cardiac massage total circulatory support purpose study feasibility DMVA application patients refractory cardiac arrest informed consent DMVA patients Vascular access hemodynamic monitoring possible patients outcomes basis report mean age patients years men women average time witnessed cardiac arrest DMVA application minutes Application minutes time skin incision immediate hemodynamic improvement Systolic diastolic blood pressures mm Hg mean cardiac output L/min mean minutes circulatory support range minutes hours cases device minutes open-chest cardiac massage OCCM similar compression rates DMVA arterial pressures percent cardiac output percent OCCM Initial arterial pH time device Serum lactate levels mumol/L mumol/L patients inadequate cardiac function cardiac failure respiratory insufficiency patient normal neurologic function DMVA cardiopulmonary bypass emergent coronary artery bypass grafting myocardial infarction complications cardiac laceration pericardiotomy patients ventricular rupture OCCM complication device DMVA feasible method acute cardiovascular stabilization victims refractory cardiac arrest Human clinical trials DMVA application resuscitative potential 